Takahashi, M., Kato, K., Okada, M., Chin, K., Kadowaki, S., Hamamoto, Y., . . . Kitagawa, Y. (2020). Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: A subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3). Esophagus.
Citación estilo ChicagoTakahashi, Masanobu, et al. "Nivolumab Versus Chemotherapy in Japanese Patients With Advanced Esophageal Squamous Cell Carcinoma: A Subgroup Analysis of a Multicenter, Randomized, Open-label, Phase 3 Trial (ATTRACTION-3)." Esophagus 2020.
Cita MLATakahashi, Masanobu, et al. "Nivolumab Versus Chemotherapy in Japanese Patients With Advanced Esophageal Squamous Cell Carcinoma: A Subgroup Analysis of a Multicenter, Randomized, Open-label, Phase 3 Trial (ATTRACTION-3)." Esophagus 2020.